Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Welsh

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 4, 2020
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear AnalysisShane Mesko, Matthew S Ning, David Lakomy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2012
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancerYuki Hayashi, Lianchun Xiao, Akihiro Suzuki, et al.
The Annals of Thoracic Surgery|October 4, 2011
Does the timing of esophagectomy after chemoradiation affect outcome?Jae Y Kim, Arlene M Correa, Ara A Vaporciyan, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trialJames Welsh, Hari Menon, Dawei Chen, et al.
Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.
Dose-Response : a Publication of International Hormesis Society|January 2, 2015
French nuclear power plants and childhood leukemiaKrzysztof W Fornalski, Mervyn Cohen, Jerry M Cuttler, et al.
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
Cancer Research Communications|September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLCJoanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
Journal for Immunotherapy of Cancer|October 27, 2020
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stromaHampartsoum B Barsoumian, Rishab Ramapriyan, Ahmed I Younes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with RadiotherapyXinyan Xu, Maliazurina B Saad, Adam Grippin, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|May 4, 2020
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear AnalysisShane Mesko, Matthew S Ning, David Lakomy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2012
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancerYuki Hayashi, Lianchun Xiao, Akihiro Suzuki, et al.
The Annals of Thoracic Surgery|October 4, 2011
Does the timing of esophagectomy after chemoradiation affect outcome?Jae Y Kim, Arlene M Correa, Ara A Vaporciyan, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trialJames Welsh, Hari Menon, Dawei Chen, et al.
Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.
Dose-Response : a Publication of International Hormesis Society|January 2, 2015
French nuclear power plants and childhood leukemiaKrzysztof W Fornalski, Mervyn Cohen, Jerry M Cuttler, et al.
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
Cancer Research Communications|September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLCJoanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
Journal for Immunotherapy of Cancer|October 27, 2020
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stromaHampartsoum B Barsoumian, Rishab Ramapriyan, Ahmed I Younes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 2, 2026
Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with RadiotherapyXinyan Xu, Maliazurina B Saad, Adam Grippin, et al.
Pageof 11